Workflow
Suburban Propane Partners, L.P. to Hold Fiscal 2025 Second Quarter Results Conference Call
Prnewswire· 2025-04-23 20:20
WHIPPANY, N.J., April 23, 2025 /PRNewswire/ -- Suburban Propane Partners, L.P. (NYSE: SPH), announced today that it has scheduled its Fiscal 2025 Second Quarter Results Conference Call for Thursday, May 8, 2025 at 9:00 AM Eastern Time. Analysts, investors and other interested parties are invited to listen to management's discussion of Fiscal 2025 Second Quarter results and business outlook by accessing the call via the internet at www.suburbanpropane.com, or by telephone as follows: Phone #: (800) 836-8184 ...
TFI International Reports on Shareholders' Voting Results for the Election of Directors
Newsfilter· 2025-04-23 20:15
MONTREAL, April 23, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of TFI International Inc. (NYSE and TSX:TFII), a North American leader in the transportation and logistics industry, held its Annual Meeting of shareholders earlier today. All candidates proposed as directors were duly elected to the Board of Directors of TFI International by a majority of the votes cast by shareholders represented by proxy at the Meeting, as follows: NAMEFORAGAINST Number%Number%Leslie Abi-Karam66,539,95698.371,099,7581.63 ...
Hagerty to Report First Quarter 2025 Results and Host Conference Call on Wednesday, May 7, 2025
Prnewswire· 2025-04-23 20:15
TRAVERSE CITY, Mich., April 23, 2025 /PRNewswire/ -- Hagerty, Inc. (NYSE: HGTY), an automotive enthusiast brand and a leading specialty vehicle insurance provider, today announced it will report its first quarter 2025 financial results before the market opens on Wednesday, May 7, 2025. Hagerty will hold a conference call to discuss the financial results at 10:00 am Eastern Time on that day. A live webcast of the conference call will be available on Hagerty's investor relations website at investor.hagerty.co ...
Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma
Prnewswire· 2025-04-23 20:15
Statistically significant and clinically meaningful progression-free survival (PFS) and overall survival (OS) data for Zepzelca® (lurbinectedin) and atezolizumab (Tecentriq®) combination underscore potential of first-line maintenance therapy for extensive-stage small cell lung cancer, a much-needed advancement for patients Long-term outcomes and survival data for Ziihera® (zanidatamab-hrii) highlight its potential to reshape the treatment paradigm for newly diagnosed HER2+ gastroesophageal cancer patients ...
TFI International Reports on Shareholders’ Voting Results for the Election of Directors
GlobeNewswire· 2025-04-23 20:15
MONTREAL, April 23, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of TFI International Inc. (NYSE and TSX: TFII), a North American leader in the transportation and logistics industry, held its Annual Meeting of shareholders earlier today. All candidates proposed as directors were duly elected to the Board of Directors of TFI International by a majority of the votes cast by shareholders represented by proxy at the Meeting, as follows: NAMEFORAGAINST Number%Number%Leslie Abi-Karam66,539,95698.371,099,758<td ...
Origin Bancorp, Inc. Reports Earnings For First Quarter 2025
GlobeNewswire· 2025-04-23 20:15
RUSTON, La., April 23, 2025 (GLOBE NEWSWIRE) -- Origin Bancorp, Inc. (NYSE: OBK) (“Origin,” “we,” “our” or the “Company”), the holding company for Origin Bank (the “Bank”), today announced net income of $22.4 million, or $0.71 diluted earnings per share (“EPS”) for the quarter ended March 31, 2025, compared to net income of $14.3 million, or $0.46 diluted earnings per share, for the quarter ended December 31, 2024. Pre-tax, pre-provision (“PTPP”)(1) earnings were $32.0 million for the quarter ended March 31 ...
Northrim BanCorp Earns $13.3 Million, or $2.38 Per Diluted Share, in First Quarter 2025
GlobeNewswire· 2025-04-23 20:15
ANCHORAGE, Alaska, April 23, 2025 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. (NASDAQ:NRIM) (“Northrim” or the “Company”) today reported net income of $13.3 million, or $2.38 per diluted share, in the first quarter of 2025, compared to $10.9 million, or $1.95 per diluted share, in the fourth quarter of 2024, and $8.2 million, or $1.48 per diluted share, in the first quarter a year ago. The increase in first quarter 2025 profitability as compared to the first quarter a year ago was primarily the result of an ...
Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
GlobeNewswire· 2025-04-23 20:15
SAN CARLOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, announced that pre-clinical data for IOV-5001, a genetically engineered, inducible, and tethered interleukin-12 (IL-12) TIL cell therapy, will be presented at the 2025 AACR Annual Meeting. In addition, five-year outcomes data from the C-144-01 stud ...
Jayud Global Logistics Files 2024 Annual Report on Form 20-F
GlobeNewswire· 2025-04-23 20:15
SHENZHEN, China, April 23, 2025 (GLOBE NEWSWIRE) -- Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company"), a leading end-to-end supply chain solution provider based in Shenzhen specializing in cross-border logistics, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission (the "SEC") on April 22, 2025. The annual report, which contains the Company’s audited consolidated statements, can be accessed ...
Gouverneur Bancorp, Inc. Announces Fiscal 2025 Second Quarter and Six Months Results
GlobeNewswire· 2025-04-23 20:15
GOUVERNEUR, N.Y., April 23, 2025 (GLOBE NEWSWIRE) -- Gouverneur Bancorp, Inc. (OTCQB: GOVB) (the “Company”), the holding company for Gouverneur Savings and Loan Association (the “Bank”), today announced the Company’s results for the second quarter and six months of fiscal year 2025, ended March 31, 2025. The Company reported net income of $118,000, or $0.11 per basic and diluted share, for the quarter ended March 31, 2025, compared to net income of $102,000, or $0.10 per basic and diluted share, for the qua ...